发布于: Android转发:0回复:3喜欢:0
回复@郁闷的_鞋套: 他以前不是说还有个$Seagen(SGEN)$ 什么临床的readout么,已经读出来了么?我都忘了//@郁闷的_鞋套:回复@JZee:Brad Loncar, biotech investor and creator of two Nasdaq-listed exchange traded funds, told Endpoints News, “I think this was the only remaining hurdle to the deal valuation. I wouldn’t be surprised to see it announced on Monday morning.” $默沙东(MRK)$ [想一下]
引用:
2022-08-13 03:31
$DAIICHI SANKYO COM(DSNKY)$ 赢了和$Seagen(SGEN)$ 的官司。

全部讨论

However, in a follow up report, WSJ said that the deal is unlikely to finalize before the pharma giant’s earnings date on July 28.The reasons for the delay are said to be an upcoming data readout for the Seagen’s (SGEN) bladder-cancer therapy Padcev and an impending outcome of a lawsuit between the company and Japanese drugmaker Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) over royalty payments.